Olberon’s business model is based on developing and profitably commercialising intellectually protected innovative medical devices which address defined medical needs. Currently we are working in the field of intravenous cannulations, innovative skin dressings , intradermal injection delivery systems as well as diagnostic ear, nose throat devices.

In the long run, we aim to establish a strategically sound product pipeline (either through in-house development, licensing, strategic alliance or merger and acquisitions) for the business to ensure our continued competitiveness, and hence a sustainable and tractable growth.